DocGo Inc. Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased
DocGo Inc. (DCGO) had Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased of 70.00 thousand shares as of 2022-06-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased · last filed 2022-11-08
- 2022-06-30: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 70.00K shares; Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased as first filed 70.00M shares.
| Period end | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased as first filed |
|---|---|---|
| 2022-06-30 | 70.00K shares 10-Q · filed 2022-11-08 | 70.00M shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |